Taken together, our data provides molecular evidence to support the epidemiological observation that both, vitamin D and calcium are needed for protection against malignant transformation of the colon and that their effect is modulated by the presence of a functional CaSR.
Introduction
Colorectal cancer (CRC), the third leading cause of death from cancer worldwide [1] is a slowly developing disease. Dietary influences account for 70-90% of CRC development, making it preventable to a great extent. Experimental, epidemiological and clinical studies, although not consistent, suggest an inverse correlation between calcium and vitamin D intake and risk for CRC [2, 3] . The Second Expert Report [4] by the World Cancer Research Fund and the American Institute for Cancer Research suggests that calcium is a factor that 'probably' decreases risk for CRC development, whereas the effects of vitamin D are 'limitedsuggestive'.
Deregulation of the dynamic balance between proliferation, differentiation, and apoptosis represents a risk for development of colonic tumors [5] . Although animal studies suggest that calcium and vitamin D regulate these anti-neoplastic processes in the colon [6] [7] [8] , clinical studies are inconsistent. This has led to a shifted focus toward combinational chemoprevention studies, which propose the existence of a cross talk between calcium and vitamin D signaling in protection against CRC. In a randomized, placebocontrolled clinical trial, Grau et al. [9] showed that only a combined supplementation of calcium and vitamin D could reduce risk of colorectal cancer. In addition, Holt et al. [10] were able to demonstrate reduced polyp formation in adenoma patients receiving calcium and vitamin D supplementation together. In another study, Fedirko et al. [11] described that high dietary calcium intake (!928 mg/d) and increased circulating 25-hydroxyvitamin D levels correlated with reduced CRC-related mortality. These studies call for a clearer understanding of the molecular mechanisms behind the cross talk between the vitamin D system and calcium signaling that could regulate anti-neoplastic effects in the colon.
Dietary vitamin D 3 is hydroxylated in the liver at carbon-25 by the vitamin D 25-hydroxylases CYP2R1 and CYP27A1 to form the precursor, 25-hydroxyvitamin D 3 (25-D 3 ). 25-D 3 bound to vitamin D binding protein (DBP) is delivered to the kidney where an additional hydroxylation step at carbon-1 by 25-D 3 1a-hydroxylase (CYP27B1) converts it to the biologically active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25-D 3 ) . Besides the kidney, several other extra-renal tissues, including the intestine, are able to synthesize and degrade 1,25-D 3 locally [12] .
The calcium-sensing receptor (CaSR) is a G-protein coupled receptor, and its promoter harbors two vitamin D response elements (VDRE) [13] . Thus, 1,25-D 3 is able to upregulate the expression of the CaSR [14, 15] . In addition to its key role in regulating calcium homeostasis, the CaSR is involved in processes controlling cell growth in several tissues [16] as evidenced e.g., in the colon of CaSR knock out mice that have hyperproliferative colonic crypts with increased susceptibility to form aberrant crypt foci [17] [18] [19] . During colorectal tumorigenesis, expression of the CaSR is lost in late-stage, undifferentiated tumors [20, 21] . On the basis of these observations, we hypothesize that the CaSR is one of the key molecules linking the anti-neoplastic effects of calcium and vitamin D. Therefore the present study evaluated whether the expression level and functionality of the CaSR influences vitamin D signaling thereby potentiating the effects of calcium in the colon.
Materials and methods

2.1.
In vivo study -animals, diet and xenograft establishment /2). At the end of the study, mice were euthanized by cervical dislocation (Fig. 1A) . The colon was collected and washed in ice-cold PBS. A small portion of the ascending colon and the tumor tissue was immediately snap frozen in liquid nitrogen. The majority of the colonic tissue was fixed in 4% buffered formalin and rolled into a plane spiral (Swiss roll), dehydrated and embedded in paraffin.
Immunohistochemistry
4 mm sections were cut and stained for Ki67 (1:400, Novus Biologicals, USA) on a Ventana Discovery XT autostainer (Ventana, USA) using cell conditioner 1 as pre-treatment, rabbit OmniMap (Ventana) as detection system, and Hematoxylin (DAKO, Austria) as counter stain. Whole section images were acquired using the automated TissueFAXS system (TissueGnostics, Austria). At least 10 intact crypts per colon were identified and the percentage of Ki67-positive cells per crypt (in both, ascending and descending colon) was quantified in a blinded fashion.
Cell culture
Moderately differentiated HT29, and well-differentiated Caco2-15 (a sub-clone of the Caco2 cell line [22] ) colon cancer cell lines were used in this study. Cells were tested for their authenticity at the DNA Diagnostic Center (UK 
Functional assays
One week post confluence, the culture medium was changed to calcium-free DMEM (Life Technologies) and the cells were exposed to either Ca 2+ (1. Proliferation was measured by counting viable cells after detaching them with trypsin using the T10 Automated cell counter (BioRad, USA). Differentiation was determined using the Alkaline Phosphatase (ALP) Colorimetric Assay Kit (Abcam, UK). ALP activity per 10 5 cells was calculated and data presented in units/ml.
Apoptosis was evaluated using the Apo-ONE Homogeneous Caspase 3/7 Assay Kit (Promega, Germany) and data were normalized to the number of viable cells. All experiments were performed at least in biological triplicates according to the manufacturer's instructions.
RNA isolation, reverse transcription and real time qRT-PCR
Snap frozen tissue was homogenized in TRIzol (Life Technologies, USA) using the Precellys 24-Dual Homogenizer (Precellys, France). RNA isolation and cDNA reverse transcription were performed as previously described [23] . Real time qRT-PCR analysis was performed on the Step One Plus using Power SYBR Green system (Life Technologies) and gene expression calculated based on the 2
ÀDDCt method and set relative to a total RNA calibrator (Clontech, USA). Primers used were: mouse Cyclin D1 (Fwd: GAACAAGCTCAAGTGGAAC; Rev: GAACTTCACATCTGTGGCA), mouse Sucrase Isomaltase (mSI) (Fwd: ACAGCAAGCCGAAAGAATCC; Rev: TTCACCATCATCCCAGAAGAG), mouse B-cell lymphoma 2 (mBCL-2) (Fwd: CATGTGTGTGGAGAGCGTCAA; Rev: GCCGGTTCAGGTACTCAGTCA), mouse Bcl-2 associated X protein (mBAX) (Fwd: TGGAGCTGCAGAGGATGATTG; Rev: GAAAACATGT-CAGCTGCCACTC) and mouse calcium-sensing receptor (mCaSR) (Fwd: GAGGCCTGGCAGGTCCTGAA; Rev: TGATGGAGTAGTTCCC-CACC). Mouse intestinal Alkaline Phosphatase (mALP) mRNA levels were detected using the TaqMan gene expression system (Mm01285814_g1, Life Technologies). Data were normalized to the expression of the housekeeping gene, mouse eukaryotic translation elongation factor 1 beta 2 (mEEF1B2) (Fwd: AGAGCTA-CATTGAGGGGTACG; Rev: GACTTGATGTGATTATACCAACGTAG). For gene expression in the human xenografts, primers used for CaSR expression analysis and housekeeping genes, human beta-2 microglobulin (hß2M), human glutaminyl-tRNA synthetase (hQARS) and human large ribosomal protein (hRPLP0) have been previously published [14, 24] .
Statistical analysis
All statistical analyses were performed using SPSS (IBM, USA) and graphs plotted using GraphPad Prism (GraphPad Software Inc. USA). Non-normally distributed data was log-transformed to achieve normal distribution. Unpaired t-test was used to compare between the two animal groups after Grubbs outlier test was performed using GraphPad Prism. Statistically significant outliers were excluded from analysis. For analysis of the 2 Â 2 factorialdesigned functional experiments, we used two-way ANOVA followed by Tukey's multiple correction. For analysis of the groups treated with or without the Calcimimetic (NPS R-568), we used one-way ANOVA followed by Tukey's multiple correction. P-values less than 0.05 were considered statistically significant. Fig. 1 . Effect of dietary vitamin D on tumor xenograft and mouse colon. Schematic representation of in vivo study. Upon arrival, mice were fed normal AIN-93G diet for 1 week, after which mice were randomly distributed into two groups receiving either a diet containing high vitamin D (2500 IU/kg diet) or low vitamin D (100 IU/kg diet). After 2 weeks of diet acclimatization, mice were injected with HT29 cells to establish tumor xenografts and fed their respective diets. At the end of the study mice were euthanized by cervical dislocation (A). We measured volume of the HT29 xenografts (B), CaSR mRNA expression in the xenografts (C), and CaSR mRNA expression in the mouse colon (D). Median, interquartile range and whiskers (min and max) are shown. Statistical significance was calculated using unpaired t-test. n = 5 animals per group except C where we identified one significant outlier in both groups (using Grubbs test) and these were excluded from analysis. ***P < 0.001.
Results
Effect of dietary vitamin D on proliferation, differentiation, apoptosis and CaSR transcription in the normal colon and in tumor xenografts
To study the anti-neoplastic functions regulated by vitamin D in vivo, we established HT29 xenografts in mice fed with a diet containing either low (100 IU/kg diet) or high (2500 IU/kg diet) concentrations of vitamin D. We found no difference in tumor volume between groups fed with low or high vitamin D (Fig. 1B) . As 1,25-D 3 has been shown to regulate CaSR expression, we determined CaSR expression in the tumor and colon of these mice. While there was no difference in CaSR expression in the tumor xenografts (Fig. 1C) , the colon of mice fed with the high vitamin D diet for 5 weeks had 2.4-fold higher CaSR expression (P < 0.001, Fig. 1D) .
The high vitamin D diet resulted in a marked decrease in the proliferative zone of colonic crypts (defined by the proliferative marker Ki67, Fig. 2A) , a 1.9-fold decrease in percentage of Ki67-positive cells along intact crypts (P < 0.001, Fig. 2B ) and a 1.6-fold decrease in expression of the proliferation marker, cyclin D1 ( Fig. 2C , P < 0.05). Expression of the intestinal differentiation marker, alkaline phosphatase (ALP) increased 92-fold ( Fig. 2D , P < 0.001) in response to high vitamin D diet whereas sucrase isomaltase (SI) expression was upregulated 1.5-fold ( Fig. 2E , P < 0.05). The apoptosis-defining BAX/BCL-2 ratio, which measures the balance between the pro-apoptotic and anti-apoptotic markers was increased 1.4-fold (Fig. 2F) (Fig. 3A) .
However, treatment of cells with the positive allosteric modulator of CaSR, NPS R-568, in the presence of 1.8 mM Ca 2+ made these cells sensitive to the anti-proliferative effect of 1,25-D 3 (Fig. 3B) . The observed anti-proliferative effect of 1,25-D 3 in Caco-2 cells was affected by the expression level of the CaSR, showing higher potency in cells overexpressing the wild-type CaSR, but no effect in cells carrying the mutant receptor (Fig. 3C ). This effect of 1,25-D 3 was further potentiated in the presence of the natural ligand (Ca 2+ )
( Fig. 3C ) and the positive allosteric modulator NPS R-568 (Fig. 3D) . , and the apoptosis-defining BAX/BCL2 ratio (F). Median, interquartile range and whiskers (min and max) are shown. Statistical significance was calculated using unpaired t-test. n = 5 animals per group. In the statistical analysis for BAX/BCL2 ratio, one significant outlier was identified in the low vitamin D group (using Grubbs test) and was excluded from analysis. ***P < 0.001, *P < 0.05.
Effect of 1,25-D 3 on differentiation in CRC cells over expressing wild type or mutant CaSR
Both calcium and vitamin D promote differentiation of colon cancer cells in culture [25] . Therefore, we assessed the differentiation potential of the stably transfected cells treated with 1 nM 1,25-D 3 in the presence or absence of the CaSR agonists Ca 2+ and NPS R-568, for 48 h. Differentiation was measured by assessing ALP activity. HT29 cells have a very low differentiating potential compared with Caco2-15 cells that are capable to differentiate spontaneously in culture [26] . Caco2-15 cells were 10-fold more differentiated than HT29 cells (Fig. 4) . Compared with vector treated control cells, both HT29 (Fig. 4A) and Caco2-15 cells (Fig. 4C) showed increased ALP activity upon treatment with 1,25-D 3 , which was further enhanced in the presence of a functional CaSR in HT29 cells. In Caco2-15 cells the strong pro-differentiating effect of 1,25-D 3 was independent of the expression level of the CaSR (Fig. 4C) Fig. 5A and C) . In the presence of Ca 2+ , 1,25-D 3 was able to further induce apoptosis in both cell lines (Fig. 5A and C) . In contrast, the dominant-negative CaSR inhibited Caspase 3/7 activity, suggesting that the CaSR has an important role in regulating apoptosis (Fig. 5) .
To confirm whether a further activation of the CaSR would affect the pro-apoptotic effects of 1,25-D 3 , we pre-treated the cells with the positive allosteric CaSR modulator NPS R-568, before treatment with 1,25-D 3 . Both in HT29 (Fig. 5B ) and Caco2-15 cells (Fig. 5D) , apoptosis was significantly higher in cells overexpressing the wildtype CaSR. The activation of the CaSR by its allosteric modulator further sensitized the cells to the pro-apoptotic effect of 1,25-D 3 . In the presence of the non-functional CaSR mutant these effects were diminished.
Discussion
There is increasing evidence that calcium and vitamin D can modify, prevent or even abrogate colorectal tumor development. In the present study we show that a high vitamin D diet reduced proliferation, increased differentiation and apoptosis, and in parallel, upregulated mRNA expression of the calcium-sensing receptor in the colon of mice. By applying a mechanistic model we demonstrate that the CaSR is a link for a direct cross talk between calcium and vitamin D signaling in the colon that facilitates 1,25-D 3 -mediated anti-neoplastic effects. We show for the first time that expression level as well as functionality of the CaSR affects the cancer preventive action of the active vitamin D 3 : the higher the expression level or activity of the CaSR, the stronger the effect of 1,25-D 3 .
We have previously reported that increasing dietary Ca 2+ led to significant downregulation of the vitamin D degrading enzyme, 1,25-dihydroxyvitamin D 3 24-hydroxylase (CYP24A1) in the colon of mice [7] . Low calcium in the diet of mice led to hyperproliferative and hypo-apoptotic colonic crypts [7, 8] . In the present in vivo study, mice fed with the high vitamin D diet exhibited significantly higher CaSR expression, fewer proliferating cells, and showed in general, downregulation of colonic proliferation and upregulation of differentiation and apoptosis in the normal colon ( Figs. 1 and 2 ). This led us to hypothesize that the CaSR could be a molecular link supporting the cross talk between calcium signaling and the vitamin D system, thereby increasing the effectiveness of these compounds as combinational chemopreventive agents in the colon.
To test this hypothesis, we transfected HT29 and Caco2-15 cells with either a full-length wild type CaSR construct, or an inactivating mutant (R185Q). We saw that the anti-neoplastic effects of 1,25-D 3 were dependent on both the amount and functionality of the CaSR. These results were confirmed by treating cells with NPS R-568, a positive allosteric modulator that increases the sensitivity of the CaSR to calcium [27] . Only the pro-differentiating effect of 1,25-D 3 in the Caco-2 cells seem to be independent of the exogenous CaSR activation. combination of these agents enhances CaSR promoter activity in the colon [15] . 1,25-D 3 can bind to the VDRE in the promoter of the CaSR gene, and regulate its expression [13] . Interestingly, 1,25-D 3 was not able to enhance CaSR expression in HT29 cells (data not shown), probably due to the high methylation level of the second CaSR promoter region, which harbors the VDRE [20] . This might explain why in the xenografts the high vitamin D diet had no effect on CaSR expression. It is however, surprising that the presence of the CaSR-DN mutant restricts the anti-neoplastic functions of 1,25-D 3 . The inactivating R185Q mutant of the CaSR is able to dimerize with endogenous CaSR and reduces the functionality of the latter [28] . We speculate that the CaSR-DN interferes with or even negatively modulates gene expression of molecules that may be downstream of the vitamin D signaling pathway, thereby suppressing the functions directly mediated by 1,25-D 3 .
Recently, Ahearn et al. [29] in a randomized, double blinded study showed that colorectal adenoma patients supplemented with calcium had lower CYP24A1 expression in the normal colonic tissue. In the same study, patients supplemented with vitamin D showed upregulation of colonic CaSR expression. Considering that CaSR expression was upregulated by vitamin D also in our in vivo model, taken together with our previous findings that vitamin D system genes can be regulated by calcium in vivo [7] , we suggest the existence of a cross talk between calcium signaling and the vitamin D system to protect the colon from neoplastic transformation. In this cross talk, the CaSR seems to play a central role. Liu et al. have also shown that vitamin D promotes its growthinhibitory actions in a CaSR-dependent manner [30] . This is further evidenced in our in vitro study where the inactivating mutation of the CaSR interferes with 1,25-D 3 -mediated anti-tumorigenic processes. Given that colonic cells acquire CaSR expression as they migrate to the crypt apex [15, 20] where a balance between apoptosis and differentiation is tightly regulated, it seems plausible that loss of the CaSR during colorectal tumorigenesis confers transformed cells resistance to calcium and vitamin D-mediated growth regulation.
In order to understand the effect of calcium and vitamin D in combinational chemoprevention, there is a need to elucidate the mechanisms that support their interplay at the molecular level. In this study we showed that the expression level and functionality of the CaSR alters 1,25-D 3 -mediated signaling. Since CaSR expression is lost during colorectal tumorigenesis, this might be a further explanation for the low responsiveness of colonic tumors to 1,25-D 3 . Our data suggest that the CaSR might become a possible target in colon cancer therapy. We have recently shown that hypermethylation and deacetylation of the CaSR promoter are responsible, at least in part, for silencing of CaSR expression in colorectal tumors [20] . Development of agents that can induce CaSR expression, and the elucidation of signaling pathways by which 1,25-D 3 and CaSR cooperate for preventing malignant transformation in the colon could help in improving outcome in patients.
